Assignee
ARCUTIS INC
US9 patents
Top patents by PatentIndex Score
US10105354B1Oct 23, 2018
Inhibition of crystal growth of roflumilast
ARCUTIS INC23 citations98
US9907788B1Mar 6, 2018
Inhibition of crystal growth of roflumilast
ARCUTIS INC31 citations98
US9895359B1Feb 20, 2018
Inhibition of crystal growth of roflumilast
ARCUTIS INC35 citations98
US9884050B1Feb 6, 2018
Inhibition of crystal growth of roflumilast
ARCUTIS INC30 citations98
US11793796B2Oct 24, 2023
Inhibition of crystal growth of roflumilast
ARCUTIS INC18 citations94
US11534493B2Dec 27, 2022
Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents
ARCUTIS INC19 citations94
US10940142B2Mar 9, 2021
Inhibition of crystal growth of roflumilast
ARCUTIS INC19 citations94
US10172841B2Jan 8, 2019
Inhibition of crystal growth of roflumilast
ARCUTIS INC21 citations94
US11129818B2Sep 28, 2021
Topical roflumilast formulation having improved delivery and plasma half life
ARCUTIS INC21 citations90